Ethicon, Inc.
Clinical trials sponsored by Ethicon, Inc., explained in plain language.
-
New surgical pad aims to stop bleeding faster in open surgery
Disease control Recruiting nowThis study compares a new absorbable pad called ETHIZIA to a standard pad (SURGICEL) for controlling mild to moderate bleeding during open surgery on the abdomen, chest, pelvis, or limbs. About 108 adults will be randomly assigned to receive one of the two pads. The main goal is …
Phase: NA • Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated May 26, 2026 09:27 UTC
-
Sling study tracks success for years
Disease control Recruiting nowThis study follows 195 women who receive the GYNECARE TVT ABBREVO sling to treat stress urinary incontinence (leaking urine with cough, sneeze, or exercise). The main goal is to see if the sling still works well 5 to 10 years after surgery. Participants will have a cough stress t…
Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
Mesh fix for prolapse: 7-Year checkup begins
Disease control Recruiting nowThis study looks at how well a mesh (GYNEMESH PS) works for women who had surgery to fix pelvic organ prolapse. About 100 women will be checked about 7 years after their surgery to see if the prolapse is still controlled. The goal is to understand long-term results and patient sa…
Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Thousands of women to be tracked for decade after pelvic mesh surgery
Knowledge-focused Recruiting nowThis study is a long-term registry that will follow 1,000 women who have had surgery using Ethicon pelvic mesh products for stress urinary incontinence or pelvic organ prolapse. The goal is to see how well the mesh works and how safe it is over 5 to 10 years. Participants will ha…
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC